Twenty years of evolving trends in racial disparities for adult kidney transplant recipients

Kidney International

Volumn 90, Issue 4, 2016, Pages 878-887

  Taber, David J ^a,b   Gebregziabher, Mulugeta ^a   Hunt, Kelly J ^a   Srinivas, Titte ^a   Chavin, Kenneth D ^a   Baliga, Prabhakar K ^a   Egede, Leonard E ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

African American; graft loss; kidney transplant; racial disparities

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ATTRIBUTABLE RISK; CAUCASIAN; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HEALTH DISPARITY; HOSPITAL ADMISSION; HUMAN; KIDNEY GRAFT; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; SOLITARY KIDNEY; TREND STUDY; ETHNOLOGY; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE DISPARITY; KIDNEY TRANSPLANTATION; MIDDLE AGED; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TRENDS; UNITED STATES;

ADULT; AFRICAN AMERICANS; DELAYED GRAFT FUNCTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTHCARE DISPARITIES; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANT RECIPIENTS; UNITED STATES; WAITING LISTS;

EID: 84996490481     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.06.029     Document Type: Article

References (46)

1. 1 Harris, M.I., Flegal, K.M., Cowie, C.C., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21 (1998), 518–524.
2. 2 Kato, N., Ethnic differences in genetic predisposition to hypertension. Hypertens Res 35 (2012), 574–581.
3. 3 Carson, A.P., Howard, G., Burke, G.L., et al. Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension 57 (2011), 1101–1107.
4. 4 Coresh, J., Selvin, E., Stevens, L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007), 2038–2047.
5. 5 U.S. Renal Data System. USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2011.
6. 6 Griva, K., Davenport, A., Harrison, M., Newman, S.P., The impact of treatment transitions between dialysis and transplantation on illness cognitions and quality of life—a prospective study. Br J Health Psychol 17 (2012), 812–827.
7. 7 Landreneau, K., Lee, K., Landreneau, M.D., Quality of life in patients undergoing hemodialysis and renal transplantation–a meta-analytic review. Nephrol Nurs J 37 (2010), 37–44.
8. 8 Rana, A., Gruessner, A., Agopian, V.G., et al. Survival benefit of solid-organ transplant in the United States. JAMA Surg 150 (2015), 252–259.
9. 9 Tonelli, M., Wiebe, N., Knoll, G., et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 11 (2011), 2093–2109.
10. 10 Opelz, G., Sengar, D.P., Mickey, M.R., Terasaki, P.I., Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5 (1973), 253–259.
11. 11 Matas, A., Smith, J., Skeans, M., et al. OPTN/SRTR 2012 annual data report: kidney. Am J Transplant 14:Suppl 1 (2014), S11–S44.
12. 12 Opelz, G., Mickey, M.R., Terasaki, P.I., Influence of race on kidney transplant survival. Transplant Proc 9 (1977), 137–142.
13. 13 Purnell TS, Luo X, Kucirka LM, et al. Reduced racial disparity in kidney transplant outcomes in the United States from 1990 to 2012 [E-pub ahead of print]. J Am Soc Nephrol. http://dx.doi.org/10.1681/ASN.2015030293. Accessed February 4, 2016.
14. 14 Ciancio, G., Burke, G.W., Suzart, K., et al. The use of daclizumab, tacrolimus and mycophenolate mofetil in African-American and Hispanic first renal transplant recipients. Am J Transplant 3 (2003), 1010–1016.
15. 15 Neylan, J.F., Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 kidney transplant study group. Transplantation 65 (1998), 515–523.
16. 16 Podder, H., Podbielski, J., Hussein, I., et al. Sirolimus improves the two-year outcome of renal allografts in African-American patients. Transplant Int 14 (2001), 135–142.
17. 17 Butkus, D.E., Meydrech, E.F., Raju, S.S., Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med 327 (1992), 840–845.
18. 18 Curtis, J.J., Kidney transplantation: racial or socioeconomic disparities?. Am J Kidney Dis 34 (1999), 756–758.
19. 19 Kalil, R., Heim-Duthoy, K., Kasiske, B., Patients with a low income have reduced renal allograft survival. Am J Kidney Dis, 20, 1992, 63.
20. 20 Schweizer, R.T., Rovelli, M., Palmeri, D., et al. Noncompliance in organ transplant recipients. Transplantation 49 (1990), 374–377.
21. 21 Young, C.J., Kew, C., Health disparities in transplantation: Focus on the complexity and challenge of renal transplantation in African Americans. Med Clin N Am 89 (2005), 1003–1031.
22. 22 Cosio, F.G., Dillon, J.J., Falkenhain, M.E., et al. Racial differences in renal allograft survival: The role of systemic hypertension. Kidney Int 47 (1995), 1136–1141.
23. 23 Cosio, F.G., Pesavento, T.E., Kim, S., et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 62 (2002), 1440–1446.
24. 24 Cosio, F.G., Hickson, L.J., Griffin, M.D., et al. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant 8 (2008), 593–599.
25. 25 Taber, D.J., Meadows, H.B., Pilch, N.A., Egede, L.E., The impact of diabetes on ethnic disparities in kidney transplantation. Ethn Dis 23 (2013), 238–244.
26. 26 Freedman, B.I., Julian, B.A., Pastan, S.O., et al. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Am J Transplant 15 (2015), 1615–1622.
27. 27 Young, C.J., Gaston, R.S., African Americans and renal transplantation: disproportionate need, limited access, and impaired outcomes. Am J Med Sci 323 (2002), 94–99.
28. 28 Siedlecki, A., Irish, W., Brennan, D.C., Delayed graft function in the kidney transplant. Am J Transplant 11 (2011), 2279–2296.
29. 29 Yarlagadda, S.G., Coca, S.G., Formica, R.N. Jr., et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 24 (2009), 1039–1047.
30. 30 Gore, J.L., Danovitch, G., Litwin, M., et al. Disparities in the utilization of live donor renal transplantation. Am J Transplant 9 (2009), 1124–1133.
31. 31 Anonymous. http://ec.europa.eu/health/blood_tissues_organs/docs/ev_20141126_factsfigures_en.pdf. November 2014. Accessed May 14, 2016.
32. 32 Patzer, R.E., Plantinga, L.C., Paul, S., et al. Variation in dialysis facility referral for kidney transplantation among patients with end-stage renal disease in Georgia. JAMA 314 (2015), 582–594.
33. 33 Roberts, J.P., Wolfe, R.A., Bragg-Gresham, J.L., et al. Effect of changing the priority of HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med 350 (2004), 545–551.
34. 34 Baxter-Lowe LA. http://2014.ashi-hla.org/sites/default/files/docs/2014/Baxter-Lowe2.pdf. October 2014. Accessed May 16, 2016.
35. 35 Stewart, D.E., Kucheryavaya, A.Y., Klassen, K.D., et al. Changes in deceased donor kidney transplantation one year after KAS implementation. Am J Transplant 16 (2016), 1834–1847.
36. 36 Padiyar, A., Hricik, D.E., Immune factors influencing ethnic disparities in kidney transplantation outcomes. Exp Rev Clin Immunol 7 (2011), 769–778.
37. 37 Malat, G.E., Culkin, C., Palya, A., et al. African American kidney transplantation survival: The ability of immunosuppression to balance the inherent pre- and post-transplant risk factors. Drugs 69 (2009), 2045–2062.
38. 38 Hricik, D.E., Knauss, T.C., Bodziak, K.A., et al. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 76 (2003), 938–942.
39. 39 Hricik, D.E., Augustine, J.J., Knauss, T.C., et al. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 83 (2007), 277–281.
40. 40 Kumar, M., Khan, S., Ranganna, K., et al. Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy. Am J Transplant 8 (2008), 574–585.
41. 41 Pallet, N., Thervet, E., Alberti, C., et al. Kidney transplant in black recipients: are African Europeans different from African Americans?. Am J Transplant 5 (2005), 2682–2687.
42. 42 Yeates, K., Wiebe, N., Gill, J., et al. Similar outcomes among black and white renal allograft recipients. J Am Soc Nephrol 20 (2009), 172–179.
43. 43 Medina-Pestana, J.O., Galante, N.Z., Tedesco-Silva, H., et al. Kidney transplantation in Brazil and its geographic disparity. J Bras Nefrol 33 (2011), 472–484.
44. 44 Medcalf JF, Andrews PA, Bankart J, et al. Poorer graft survival in ethnic minorities: results from a multi-centre UK study of kidney transplant outcomes. Clin Nephrol. 2044;75:294–301.
45. 45 Malek, S.K., Keys, B.J., Kumar, S., et al. Racial and ethnic disparities in kidney transplantation. Transplant Int 24 (2011), 419–424.
46. 46 Fine, J.P., Gray, R.J., A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999), 496–509.